Merck naming troubles continue

Share this article:

Same-name problems continue to plague US-based and Germany-based Mercks. Bloomberg reports that while confusion has been an ongoing concern since the companies split in the early 20th century, a recent protest by the StopAIDS group is further proof that a different home base is not enough for activists to go on.

The latest problem is that activists protested the German Merck, known as Merck KGaA, in front of which they pitched a complaint against its move to block low-cost copies of patented drugs from flowing into South Africa, but the company that is actually involved is the Merck which has headquarters in New Jersey.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.